debrisoquin has been researched along with Bright Disease in 1 studies
Debrisoquin: An adrenergic neuron-blocking drug similar in effects to GUANETHIDINE. It is also noteworthy in being a substrate for a polymorphic cytochrome P-450 enzyme. Persons with certain isoforms of this enzyme are unable to properly metabolize this and many other clinically important drugs. They are commonly referred to as having a debrisoquin 4-hydroxylase polymorphism.
Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Böszörményi, E | 1 |
| Farsang, C | 1 |
| Morvai, V | 1 |
1 other study available for debrisoquin and Bright Disease
| Article | Year |
|---|---|
Clinical observation with debrisoquinsulphate (Tendor) in essential hypertension and glomerulonephritis.
Topics: Adult; Aged; Debrisoquin; Female; Glomerulonephritis; Humans; Hypertension; Isoquinolines; Male; Mid | 1978 |